191 related articles for article (PubMed ID: 16353205)
1. Classic Kaposi sarcoma. Which KSHV-seropositive individuals are at risk?
Guttman-Yassky E; Dubnov J; Kra-Oz Z; Friedman-Birnbaum R; Silbermann M; Barchana M; Bergman R; Sarid R
Cancer; 2006 Jan; 106(2):413-9. PubMed ID: 16353205
[TBL] [Abstract][Full Text] [Related]
2. A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma.
Brown EE; Fallin MD; Goedert JJ; Chen R; Whitby D; Foster CB; Lauria C; Alberg AJ; Messina A; Montella M; Rezza G; Vitale F; Chanock SJ;
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):633-7. PubMed ID: 15767342
[TBL] [Abstract][Full Text] [Related]
3. Infection with Kaposi's sarcoma-associated herpesvirus among families of patients with classic Kaposi's sarcoma.
Guttman-Yassky E; Kra-Oz Z; Dubnov J; Friedman-Birnbaum R; Segal I; Zaltzman N; Roth T; Schwartz F; Linn S; Rozenman D; David M; Silbermann M; Barchana M; Bergman R; Sarid R
Arch Dermatol; 2005 Nov; 141(11):1429-34. PubMed ID: 16301390
[TBL] [Abstract][Full Text] [Related]
4. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J
J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468
[TBL] [Abstract][Full Text] [Related]
5. Classic kaposi sarcoma: epidemiology and risk factors.
Iscovich J; Boffetta P; Franceschi S; Azizi E; Sarid R
Cancer; 2000 Feb; 88(3):500-17. PubMed ID: 10649240
[TBL] [Abstract][Full Text] [Related]
6. Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity.
Brown EE; Fallin D; Ruczinski I; Hutchinson A; Staats B; Vitale F; Lauria C; Serraino D; Rezza G; Mbisa G; Whitby D; Messina A; Goedert JJ; Chanock SJ
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):926-34. PubMed ID: 16702372
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of Kaposi's sarcoma-associated herpesvirus in healthy adults in Israel.
Iscovich J; Fischbein A; Fisher-Fischbein J; Freedman LS; Eng SM; Boffetta P; Vudovich A; Glasman C; Goldschmidt R; Livingston M; Heger-Maslansky B; Brennan P; Moore PS
Anticancer Res; 2000; 20(3B):2119-22. PubMed ID: 10928163
[TBL] [Abstract][Full Text] [Related]
8. Intrafamiliar transmission of Kaposi's sarcoma-associated herpesvirus and seronegative infection in family members of classic Kaposi's sarcoma patients.
Mancuso R; Brambilla L; Agostini S; Biffi R; Hernis A; Guerini FR; Agliardi C; Tourlaki A; Bellinvia M; Clerici M
J Gen Virol; 2011 Apr; 92(Pt 4):744-51. PubMed ID: 21216985
[TBL] [Abstract][Full Text] [Related]
9. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
10. Asymmetrical transmission of human herpesvirus 8 among spouses of patients with Kaposi sarcoma.
Dupuy A; Schulz T; Chevret S; Agbalika F; Pellet C; Janier M; Dupin N; Vérola O; Calvo F; Lebbé C
Br J Dermatol; 2009 Mar; 160(3):540-5. PubMed ID: 19077076
[TBL] [Abstract][Full Text] [Related]
11. Familial clustering of classic Kaposi sarcoma.
Guttman-Yassky E; Cohen A; Kra-Oz Z; Friedman-Birnbaum R; Sprecher E; Zaltzman N; Friedman E; Silbermann M; Rubin D; Linn S; Whitby D; Gideoni O; Pollack S; Bergman R; Sarid R
J Infect Dis; 2004 Jun; 189(11):2023-6. PubMed ID: 15143469
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for human herpesvirus 8 seropositivity in the AIDS Cancer Cohort Study.
Mbulaiteye SM; Atkinson JO; Whitby D; Wohl DA; Gallant JE; Royal S; Goedert JJ; Rabkin CS
J Clin Virol; 2006 Apr; 35(4):442-9. PubMed ID: 16414306
[TBL] [Abstract][Full Text] [Related]
14. Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma.
Brown EE; Whitby D; Vitale F; Marshall V; Mbisa G; Gamache C; Lauria C; Alberg AJ; Serraino D; Cordiali-Fei P; Messina A; Goedert JJ
Cancer; 2006 Nov; 107(9):2282-90. PubMed ID: 16998933
[TBL] [Abstract][Full Text] [Related]
15. Demographic indicators and risk of infection with human herpesvirus type 8 in Central Italy.
Valdarchi C; Serraino D; Cordiali Fei P; Castilletti C; Trento E; Farchi F; Rezza G;
Infection; 2007 Feb; 35(1):22-5. PubMed ID: 17297585
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against Kaposi sarcoma-associated herpes virus (KSHV) complement control protein (KCP) in infected individuals.
Okroj M; Spiller OB; Korodi Z; Tedeschi R; Dillner J; Blom AM
Vaccine; 2007 Nov; 25(48):8102-9. PubMed ID: 17964697
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and clinical characteristics of classic Kaposi's sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease.
Mohanna S; Maco V; Bravo F; Gotuzzo E
Int J Infect Dis; 2005 Sep; 9(5):239-50. PubMed ID: 16095940
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma-associated herpesvirus transmission and primary infection.
Bagni R; Whitby D
Curr Opin HIV AIDS; 2009 Jan; 4(1):22-6. PubMed ID: 19339936
[TBL] [Abstract][Full Text] [Related]
20. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus.
Inoue N; Spira T; Lam L; Corchero JL; Luo W
J Med Virol; 2004 Oct; 74(2):202-6. PubMed ID: 15332267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
